Sorafenib targets VEGFR-2 and -3, PDGFR-b, Flt-3, and c-Kit and is used in the treatment of hepatocellular carcinoma and renal cell carcinoma. The gene discussed is KIT; the disease is hereditary clear cell renal cell carcinoma.